Advertisement

Advertisement

VRCA Stock Latest News

Verrica Pharmaceuticals Earnings Call Highlights Growth, Strain

Company AnnouncementsVerrica Pharmaceuticals Earnings Call Highlights Growth, Strain

Verrica Pharmaceuticals reports Q1 adjusted EPS (41c), consensus (59c)

PremiumThe Fly

Verrica Pharmaceuticals reports Q1 adjusted EPS (41c), consensus (59c)

11d ago

Verrica Pharmaceuticals: Focused Ycanth Rollout and Underpenetrated Pediatric Market Drive Attractive Risk‑Reward and Support Buy Rating

PremiumRatings

Verrica Pharmaceuticals: Focused Ycanth Rollout and Underpenetrated Pediatric Market Drive Attractive Risk‑Reward and Support Buy Rating

2M ago

Verrica Pharmaceuticals reports Q4 adjusted EPS (51c), consensus (79c)

PremiumThe Fly

Verrica Pharmaceuticals reports Q4 adjusted EPS (51c), consensus (79c)

2M ago

Verrica Pharmaceuticals (VRCA) Q4 Earnings Cheat Sheet

PremiumPre-Earnings

Verrica Pharmaceuticals (VRCA) Q4 Earnings Cheat Sheet

3M ago

Five new option listings and fourteen option delistings on February 23rd

PremiumThe FlyFive new option listings and fourteen option delistings on February 23rd

3M ago

Verrica Pharmaceuticals appoints Chapman as Chief Commercial Officer

The Fly

Verrica Pharmaceuticals appoints Chapman as Chief Commercial Officer

3M ago

Verrica Pharmaceuticals Launches Ycanth for treatment of Molluscum in Japan

The Fly

Verrica Pharmaceuticals Launches Ycanth for treatment of Molluscum in Japan

3M ago

YCANTH Phase 3 Wart Study Puts Verrica in Focus While Veeva Extends Its Clinical Footprint

PremiumCompany Announcements

YCANTH Phase 3 Wart Study Puts Verrica in Focus While Veeva Extends Its Clinical Footprint

4M ago

Verrica announces first patient dosed in program evaluating YCANTH

PremiumThe Fly

Verrica announces first patient dosed in program evaluating YCANTH

5M ago

Verrica Pharmaceuticals Adds Caligan Partner to Board

PremiumCompany Announcements

Verrica Pharmaceuticals Adds Caligan Partner to Board

5M ago

Verrica Pharmaceuticals upgraded to Buy from Hold at Brookline

PremiumThe Fly

Verrica Pharmaceuticals upgraded to Buy from Hold at Brookline

5M ago

Verrica Pharmaceuticals files to sell 14.76M shares of common stock for holders

PremiumThe FlyVerrica Pharmaceuticals files to sell 14.76M shares of common stock for holders

5M ago

Verrica Pharmaceuticals: Hold Rating Amid Strategic Debt Retirement and Dilution Concerns

Ratings

Verrica Pharmaceuticals: Hold Rating Amid Strategic Debt Retirement and Dilution Concerns

6M ago

Verrica Pharmaceuticals Secures $50M Financing Deal

Company Announcements

Verrica Pharmaceuticals Secures $50M Financing Deal

6M ago

Verrica Pharmaceuticals announces private placement financing of $50M

PremiumThe Fly

Verrica Pharmaceuticals announces private placement financing of $50M

6M ago

Verrica Pharmaceuticals Reports Strong Growth Amid Challenges

PremiumCompany Announcements

Verrica Pharmaceuticals Reports Strong Growth Amid Challenges

6M ago

Verrica Pharmaceuticals Reports Q3 2025 Earnings

PremiumCompany Announcements

Verrica Pharmaceuticals Reports Q3 2025 Earnings

6M ago

Verrica Pharmaceuticals reports Q3 adjusted EPS 13c, consensus (84c)

PremiumThe Fly

Verrica Pharmaceuticals reports Q3 adjusted EPS 13c, consensus (84c)

6M ago

Verrica Pharmaceuticals presents new data on VP-315 from Phase 2 trial

PremiumThe FlyVerrica Pharmaceuticals presents new data on VP-315 from Phase 2 trial

6M ago

VRCA Earnings this Week: How Will it Perform?

Pre-Earnings

VRCA Earnings this Week: How Will it Perform?

7M ago

Verrica Pharmaceuticals initiated with a Buy at Lucid Capital

The Fly

Verrica Pharmaceuticals initiated with a Buy at Lucid Capital

7M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >